Comparison of Allograft, Xenograft and Combined Grafting in Maxillary Sinus Augmentation
SINUS-GRAFT
Radiographic, Histological and Immunohistochemical Evaluation of Allograft, Xenograft, and Combined Grafting in Maxillary Sinus Floor Augmentation: A Prospective Randomized Clinical Study
1 other identifier
interventional
37
1 country
1
Brief Summary
This prospective randomized clinical study evaluates and compares three different grafting approaches (allograft, xenograft, and combined grafting) used in lateral maxillary sinus augmentation prior to dental implant placement. Patients with posterior maxillary bone deficiency (residual bone height ≤4 mm) undergoing sinus lift surgery were randomly assigned to one of three grafting groups. Cone-beam computed tomography (CBCT) was used to assess bone height before surgery, immediately after grafting, and at 6 months. During implant placement at 6 months, bone biopsy samples were collected from the grafted sites for histological and immunohistochemical evaluation. The study aims to assess vertical bone gain, graft height stability, and biological bone healing using osteocalcin, osteopontin, and RUNX2 markers. The results are intended to provide clinically relevant information regarding the volumetric and biological behavior of different graft materials used in maxillary sinus augmentation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 24, 2024
CompletedFirst Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 12, 2026
CompletedFebruary 12, 2026
February 1, 2026
1.8 years
February 5, 2026
February 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vertical Bone Height Gain
Vertical bone height gain following lateral maxillary sinus augmentation, measured using cone-beam computed tomography (CBCT).
6 months
Secondary Outcomes (3)
Graft Height Loss
6 months
Histological New Bone Formation
6 months
Immunohistochemical Expression of Osteogenic Markers
6 months
Study Arms (4)
Control Group
EXPERIMENTALPatients received dental implant placement without sinus augmentation. Bone biopsy samples were obtained during implant placement for histological and immunohistochemical evaluation.
Allograft Group
EXPERIMENTALPatients underwent lateral maxillary sinus augmentation using allograft material prior to dental implant placement. Bone biopsies were obtained at implant placement for histological and immunohistochemical analyses.
Xenograft Group
EXPERIMENTALPatients underwent lateral maxillary sinus augmentation using xenograft material prior to dental implant placement. Bone biopsies were obtained at implant placement for histological and immunohistochemical analyses.
Combined Graft Group
EXPERIMENTALPatients underwent lateral maxillary sinus augmentation using a combination of allograft and xenograft materials prior to dental implant placement. Bone biopsies were obtained at implant placement for histological and immunohistochemical analyses.
Interventions
Lateral sinus floor elevation was performed using allograft material prior to dental implant placement.
Lateral sinus floor elevation was performed using xenograft material prior to dental implant placement.
Lateral sinus floor elevation was performed using a combination of allograft and xenograft materials prior to dental implant placement.
Dental implant placement was performed without sinus augmentation. Bone biopsy samples were obtained from the implant site during implant placement for histological and immunohistochemical evaluation.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 75 years.
- Patients presenting with posterior maxillary edentulism requiring dental implant rehabilitation.
- Residual alveolar bone height of 4 mm or less, indicating the need for lateral maxillary sinus augmentation.
- Patients suitable for lateral sinus lift surgery based on clinical and radiographic evaluation.
- Ability to provide written informed consent.
You may not qualify if:
- Systemic conditions that could affect bone healing (e.g., uncontrolled diabetes, metabolic bone diseases).
- History of radiotherapy or chemotherapy to the head and neck region.
- Active sinus pathology or chronic sinusitis.
- Heavy smoking (more than 10 cigarettes per day).
- Pregnancy or lactation.
- Use of medications known to affect bone metabolism.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tokat Gaziosmanpaşa University Faculty of Dentistry
Tokat Province, Tokat Province, 60230, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Histological and immunohistochemical evaluations were performed by a blinded examiner.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 12, 2026
Study Start
June 30, 2022
Primary Completion
April 24, 2024
Study Completion
April 24, 2024
Last Updated
February 12, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared.